Institution
Vall d'Hebron Institut de Recerca
Also known as: Vall d'Hebron Research Institute · VHIR · VHIR-CERCA
- 27running trials
- 35closed trials
- 11,688publications (OpenAlex)
Running trials
Active, not recruiting
Recruiting
Recruiting
[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Recruiting
Recruiting
A PHASE I STUDY OF THE CEACAM5 x CD3 ANTIBODY NILK-2301 IN COLORECTAL CANCER
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruiting
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Recruiting
Active, not recruiting
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
Recruiting
Active, not recruiting
Active, not recruiting
ADHD Remote Technology Study of Cardiometabolic Risk Factors and Medication Adherence
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers3 recruiting
- Prostate cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Diabetic eye disease1 recruiting
- Haemophilia1 recruiting
- Head and neck cancer1 recruiting
- Sarcoma1 recruiting
- Thyroid cancer1 recruiting
Closed trials
Completed
Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Terminated
Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy
Completed
Active, not recruiting
Completed
Completed
Completed
Pembrolizumab Plus Lenvatinib in Combination with Belzutifan in Solid Tumors
Completed
Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Completed
Completed
An open-label Phase 1 study of NEO-PTC-01 in patients with advanced or metastatic melanoma
Completed
Completed
ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19
Active, not recruiting
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Registry name variants (3)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Vall D'hebron Institut De Recerca
Barcelona, 08035
56 trials
Vall d'Hebron Institute of Research
Barcelona, 08035
5 trials
Vall d'Hebron Research Institute
Barcelona, 8035
2 trials
Conditions
Diseases this institution publishes on or runs trials for.
- Migraine43 works · 1 trial
- Multiple sclerosis34 works · 0 trials
- Bronchiectasis25 works · 0 trials
- Aortic aneurysm12 works · 0 trials
- Neuroblastoma11 works · 0 trials
- Antiphospholipid syndrome11 works · 0 trials
- Sickle cell disease9 works · 2 trials
- Optic neuritis4 works · 0 trials
- Mitochondrial disease3 works · 0 trials
Institution data: ROR 01d5vx451 (CC0-1.0)Updated 15 Nov 2026